BioStem Technologies, Inc. (BSEM)
5.07
-0.01
(-0.20%)
USD |
OTCM |
Mar 20, 16:00
BioStem Technologies Research and Development Expense (Quarterly) : 1.958M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.941M |
| Iovance Biotherapeutics, Inc. | 71.20M |
| Protokinetix, Inc. | 0.0242M |
| GB Sciences, Inc. | -- |
| Travere Therapeutics, Inc. | 57.87M |